Delivery Order SPE2DB24D6041-SPE2DB25FKBVV

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3304|SPE2DB25FW5X7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 mg Mesalamine suppositories, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a ceiling value of $2,879.07 and is a Firm Fixed Price Delivery Order that runs through March 26, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,438.64, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price, Delivery Order contract with an ultimate completion date of April 2, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 mg Mesalamine suppositories, a medication used to treat ulcerative colitis. The contract has a ceiling value of $1,030.00 and is a firm fixed price delivery order with a period of performance through May 13, 2025. The contract is not set aside for any specific...
This federal contract award is for the delivery of Mesalamine 1,000 mg suppositories to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,968.88 and an ultimate completion date of March 28, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.89, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with award ID SPE2DX15D1053|SPE2DX25F6JTQ, is for the supply of Mesalamine 1,000 mg suppositories. The contract has a ceiling value of $1,161.84 and is a firm fixed-price delivery order with a completion date of March 4, 2025. The contract was not set aside for any specific business...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,929.33, is a Firm Fixed Price Delivery Order for the supply of 4,567,795,600 units of Mesalamine 1,000 mg Suppositories. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,828.45, is for the delivery of Mesalamine 1,000 mg suppositories. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. This order is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.12, is a delivery order issued by the Defense Logistics Agency (DLA) for the procurement of 4,567,342,783 units of Mesalamine 1,000 mg suppositories. The contract has an ultimate completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat conditions such as ulcerative colitis. The award has a ceiling value of $1,184.05 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 28, 2025. The contract is not designated with a...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBVV
    Delivery Order

This federal contract award, with ID SPE2DB24D6041|SPE2DB25FKBVV, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine 1,000 mg suppositories, a medication used to treat ulcerative colitis. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,149.21 and an ultimate completion date of March 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/21/25, 9:54 AM